Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uric acid: a potential biomarker of multiple sclerosis and of its disability.
Moccia M, Lanzillo R, Palladino R, Russo C, Carotenuto A, Massarelli M, Vacca G, Vacchiano V, Nardone A, Triassi M, Morra VB. Moccia M, et al. Among authors: carotenuto a. Clin Chem Lab Med. 2015 Apr;53(5):753-9. doi: 10.1515/cclm-2014-0744. Clin Chem Lab Med. 2015. PMID: 25241733
Diagnostic challenges of Parkinsonism occurring in multiple sclerosis.
Moccia M, Erro R, Montella S, Carotenuto A, Pappatà S, Orefice G. Moccia M, et al. Among authors: carotenuto a. Acta Neurol Belg. 2015 Sep;115(3):513-5. doi: 10.1007/s13760-014-0368-x. Epub 2014 Oct 12. Acta Neurol Belg. 2015. PMID: 25308110 No abstract available.
Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study.
Lanzillo R, Moccia M, Carotenuto A, Vacchiano V, Satelliti B, Panetta V, Brescia Morra V. Lanzillo R, et al. Among authors: carotenuto a. Mult Scler. 2015 Aug;21(9):1215-6. doi: 10.1177/1352458514562989. Epub 2015 Feb 6. Mult Scler. 2015. PMID: 25662354 Clinical Trial. No abstract available.
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
Moccia M, Lanzillo R, Costabile T, Russo C, Carotenuto A, Sasso G, Postiglione E, De Luca Picione C, Vastola M, Maniscalco GT, Palladino R, Brescia Morra V. Moccia M, et al. Among authors: carotenuto a. J Neurol. 2015;262(4):961-7. doi: 10.1007/s00415-015-7666-y. Epub 2015 Feb 12. J Neurol. 2015. PMID: 25673130
The Framingham cardiovascular risk score in multiple sclerosis.
Moccia M, Lanzillo R, Palladino R, Maniscalco GT, De Rosa A, Russo C, Massarelli M, Carotenuto A, Postiglione E, Caporale O, Triassi M, Brescia Morra V. Moccia M, et al. Among authors: carotenuto a. Eur J Neurol. 2015 Aug;22(8):1176-83. doi: 10.1111/ene.12720. Epub 2015 Apr 27. Eur J Neurol. 2015. PMID: 25912468
The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells.
Damiano S, Sasso A, De Felice B, Terrazzano G, Bresciamorra V, Carotenuto A, Orefice NS, Orefice G, Vacca G, Belfiore A, Santillo M, Mondola P. Damiano S, et al. Among authors: carotenuto a. Brain Res Bull. 2015 Sep;118:1-6. doi: 10.1016/j.brainresbull.2015.08.009. Epub 2015 Sep 3. Brain Res Bull. 2015. PMID: 26327496 Clinical Trial.
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression.
Moccia M, Lanzillo R, Palladino R, Chang KC, Costabile T, Russo C, De Rosa A, Carotenuto A, Saccà F, Maniscalco GT, Brescia Morra V. Moccia M, et al. Among authors: carotenuto a. Mult Scler. 2016 Apr;22(5):659-67. doi: 10.1177/1352458515599075. Epub 2015 Sep 11. Mult Scler. 2016. PMID: 26362896
Quality of life and cognitive functions in early onset multiple sclerosis.
Lanzillo R, Chiodi A, Carotenuto A, Magri V, Napolitano A, Liuzzi R, Costabile T, Rainone N, Freda MF, Valerio P, Brescia Morra V. Lanzillo R, et al. Among authors: carotenuto a. Eur J Paediatr Neurol. 2016 Jan;20(1):158-63. doi: 10.1016/j.ejpn.2015.08.005. Epub 2015 Sep 3. Eur J Paediatr Neurol. 2016. PMID: 26387071
340 results